X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adenocarcinoma (5) 5
humans (5) 5
index medicus (5) 5
lung cancer (5) 5
lung neoplasms - genetics (4) 4
mutation (4) 4
oncology (4) 4
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - therapy (3) 3
cohort studies (3) 3
female (3) 3
gene (3) 3
lung neoplasms - pathology (3) 3
lung neoplasms - therapy (3) 3
male (3) 3
middle aged (3) 3
non-small cell lung cancer (3) 3
pik3ca (3) 3
adenocarcinoma - genetics (2) 2
adenocarcinoma - pathology (2) 2
adenocarcinoma - therapy (2) 2
aged (2) 2
aged, 80 and over (2) 2
cancer (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
carcinoma, squamous cell - genetics (2) 2
carcinoma, squamous cell - pathology (2) 2
carcinoma, squamous cell - therapy (2) 2
chemotherapy (2) 2
class i phosphatidylinositol 3-kinases (2) 2
exons - genetics (2) 2
gene frequency (2) 2
genetic heterogeneity (2) 2
high-throughput nucleotide sequencing - methods (2) 2
neoplasms, second primary - genetics (2) 2
neoplasms, second primary - pathology (2) 2
phosphatidylinositol 3-kinases - genetics (2) 2
pi3k (2) 2
prognosis (2) 2
resistance (2) 2
respiratory system (2) 2
survival analysis (2) 2
abridged index medicus (1) 1
achaete-scute homolog 1 (1) 1
achaete‐scute homolog 1 (1) 1
activation (1) 1
amplicon (1) 1
amplification (1) 1
analysis (1) 1
antineoplastic agents - pharmacology (1) 1
basic helix-loop-helix transcription factors - metabolism (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - genetics (1) 1
cancer therapies (1) 1
cancer-cells (1) 1
carcinoma, neuroendocrine - genetics (1) 1
carcinoma, neuroendocrine - pathology (1) 1
carcinoma, non-small-cell lung - diagnosis (1) 1
carcinomas (1) 1
cell culture techniques (1) 1
cell lung-cancer (1) 1
cetuximab - pharmacology (1) 1
chemoresistance (1) 1
classification (1) 1
clinical research paper (1) 1
colon-cancer (1) 1
colorectal cancer (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - genetics (1) 1
colorectal neoplasms - pathology (1) 1
colorectal neoplasms, hereditary nonpolyposis - drug therapy (1) 1
colorectal neoplasms, hereditary nonpolyposis - genetics (1) 1
colorectal neoplasms, hereditary nonpolyposis - pathology (1) 1
comprehensive molecular characterization (1) 1
cooccurring genomic alterations (1) 1
dependence (1) 1
diagnosis (1) 1
differentiation (1) 1
dna mismatch repair (1) 1
dna mutational analysis (1) 1
dna, neoplasm - analysis (1) 1
dna, neoplasm - genetics (1) 1
dna, neoplasm - isolation & purification (1) 1
driver mutations (1) 1
e3 ligase (1) 1
epidermal growth factor receptors (1) 1
experimental design (1) 1
expression (1) 1
factor receptor mutations (1) 1
flow cytometry (1) 1
fluorescence (1) 1
fluorescent antibody technique (1) 1
formalin-fixed (1) 1
gastroenterology & hepatology (1) 1
heterogeneity (1) 1
high-throughput nucleotide sequencing (1) 1
histology (1) 1
identification (1) 1
identify (1) 1
immunohistochemistry (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 02/2016, Volume 138, Issue 4, pp. 927 - 938
Journal Article
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2018, Volume 24, Issue 13, pp. 3087 - 3096
Purpose: KEAP1 and NFE2L2 mutations are associated with impaired prognosis in a variety of cancers and with squamous cell carcinoma formation in non-small cell... 
CANCER-CELLS | E3 LIGASE | ACTIVATION | TRANSCRIPTION FACTOR NRF2 | ONCOLOGY | PROTEASOMAL DEGRADATION | ADENOCARCINOMA | MUTATIONAL LANDSCAPE | RESISTANCE | CHEMORESISTANCE | INDUCTION
Journal Article
Gut, ISSN 0017-5749, 08/2016, Volume 65, Issue 8, pp. 1296 - 1305
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2015, Volume 10, Issue 7, pp. 1049 - 1057
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 2, pp. 1315 - 1326
Journal Article
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 12/2018
Although KRAS mutations in NSCLC have been considered mutually exclusive driver mutations for a long time, there is now growing evidence that KRAS-mutated... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.